company background image
6090 logo

Human Metabolome Technologies TSE:6090 Stock Report

Last Price

JP¥650.00

Market Cap

JP¥3.8b

7D

-1.2%

1Y

-15.6%

Updated

23 Jun, 2024

Data

Company Financials

Human Metabolome Technologies, Inc.

TSE:6090 Stock Report

Market Cap: JP¥3.8b

6090 Stock Overview

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.

6090 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends3/6

Human Metabolome Technologies, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Human Metabolome Technologies
Historical stock prices
Current Share PriceJP¥650.00
52 Week HighJP¥777.00
52 Week LowJP¥588.00
Beta0.58
11 Month Change0.78%
3 Month Change1.25%
1 Year Change-15.58%
33 Year Change-25.29%
5 Year Change-29.42%
Change since IPO-77.13%

Recent News & Updates

Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00

Jun 07
Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00

Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00

May 22
Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00

Human Metabolome Technologies (TSE:6090) Is Paying Out A Larger Dividend Than Last Year

Apr 06
Human Metabolome Technologies (TSE:6090) Is Paying Out A Larger Dividend Than Last Year

Recent updates

Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00

Jun 07
Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00

Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00

May 22
Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00

Human Metabolome Technologies (TSE:6090) Is Paying Out A Larger Dividend Than Last Year

Apr 06
Human Metabolome Technologies (TSE:6090) Is Paying Out A Larger Dividend Than Last Year

Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00

Mar 23
Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00

Human Metabolome Technologies (TSE:6090) Will Pay A Larger Dividend Than Last Year At ¥15.00

Feb 26
Human Metabolome Technologies (TSE:6090) Will Pay A Larger Dividend Than Last Year At ¥15.00

Shareholder Returns

6090JP Life SciencesJP Market
7D-1.2%-0.6%-0.6%
1Y-15.6%-39.7%17.8%

Return vs Industry: 6090 exceeded the JP Life Sciences industry which returned -39.7% over the past year.

Return vs Market: 6090 underperformed the JP Market which returned 17.8% over the past year.

Price Volatility

Is 6090's price volatile compared to industry and market?
6090 volatility
6090 Average Weekly Movement2.1%
Life Sciences Industry Average Movement5.0%
Market Average Movement3.9%
10% most volatile stocks in JP Market7.4%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 6090 has not had significant price volatility in the past 3 months.

Volatility Over Time: 6090's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200357Katsuhito Hashizumewww.humanmetabolome.com

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan. The company provides metabolome analysis services; and global profiling, targeted assays, flux analysis, and lipidomics services. It also develops biomarkers, such as Phosphorylethanolamine, a biomarker for major depressive disorder and measured in blood plasma.

Human Metabolome Technologies, Inc. Fundamentals Summary

How do Human Metabolome Technologies's earnings and revenue compare to its market cap?
6090 fundamental statistics
Market capJP¥3.85b
Earnings (TTM)JP¥285.00m
Revenue (TTM)JP¥1.34b

13.5x

P/E Ratio

2.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6090 income statement (TTM)
RevenueJP¥1.34b
Cost of RevenueJP¥484.00m
Gross ProfitJP¥855.00m
Other ExpensesJP¥570.00m
EarningsJP¥285.00m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 09, 2024

Earnings per share (EPS)48.18
Gross Margin63.85%
Net Profit Margin21.28%
Debt/Equity Ratio10.4%

How did 6090 perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

21%

Payout Ratio

Does 6090 pay a reliable dividends?

See 6090 dividend history and benchmarks
When do you need to buy 6090 by to receive an upcoming dividend?
Human Metabolome Technologies dividend dates
Ex Dividend DateJun 27 2024
Dividend Pay DateSep 09 2024
Days until Ex dividend3 days
Days until Dividend pay date77 days

Does 6090 pay a reliable dividends?

See 6090 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.